{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:05:48Z","timestamp":1789765548234,"version":"4.0.1"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pcad.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:42:54Z","timestamp":1789515774000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic testing for dilated and arrhythmogenic cardiomyopathies \u2013 A primer for cardiologists"],"prefix":"10.1016","author":[{"given":"John C.","family":"Dillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2026.09.002_bb0005","author":"Robert Guthrie Legacy Project"},{"key":"10.1016\/j.pcad.2026.09.002_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001700","article-title":"Care in specialized centers and data sharing increase agreement in hypertrophic cardiomyopathy genetic test interpretation","volume":"10","author":"Furqan","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0015","series-title":"Genetic Testing Market Size Expected to Reach USD 91.30 Bn by 2034 [Internet]","year":"2024"},{"key":"10.1016\/j.pcad.2026.09.002_bb0020","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/eurheartj\/ehab895","article-title":"Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European society of cardiology council on cardiovascular genomics","volume":"43","author":"Arbustini","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tcm.2020.07.006","article-title":"Arrhythmogenic cardiomyopathy: an in-depth look at molecular mechanisms and clinical correlates","volume":"31","author":"Costa","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004682","article-title":"Prevalence of pathogenic gene mutations and prognosis do not differ in isolated left ventricular dysfunction compared with dilated cardiomyopathy","volume":"11","author":"Hazebroek","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0035","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cardfail.2024.09.015","article-title":"Genetic testing practices and pathological assessments in patients with end-stage heart failure undergoing heart transplantation and left ventricular assist device use","volume":"31","author":"Silver","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0040","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0045","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1253\/circj.CJ-19-1176","article-title":"Prognosis and clinical characteristics of dilated cardiomyopathy with family history via pedigree analysis","volume":"84","author":"Marume","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0050","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000329","article-title":"Inpatient detection of cardiac-inherited disease: the impact of improving family history taking","volume":"3","author":"Waddell-Smith","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.pcad.2026.09.002_bb0060","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","article-title":"Light chain amyloidosis: patient experience survey from the amyloidosis research consortium","volume":"32","author":"Lousada","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.pcad.2026.09.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005521","article-title":"Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the Copenhagen city heart study","volume":"10","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2026.09.002_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2026.09.002_bb0075","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1093\/eurheartj\/ehaf605","article-title":"Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure","volume":"46","author":"Mora-Ayestar\u00e1n","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ehjci\/jead184","article-title":"Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype\u2013phenotype correlation","volume":"25","author":"De Frutos","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2026.09.002_bb0085","author":"Crawford"},{"key":"10.1016\/j.pcad.2026.09.002_bb0090","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/s41436-019-0582-2","article-title":"A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy","volume":"21","author":"Catchpool","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0095","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/med-2020-0150","article-title":"Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy","volume":"15","author":"Marey","year":"2020","journal-title":"Open Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy\u2014a heart failure society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2014a heart failure society of America practice guideline","volume":"15","author":"Hershberger","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0120","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1093\/eurheartj\/ehaf571","article-title":"Clinical care of family members of patients with dilated cardiomyopathy","volume":"46","author":"Verdonschot","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0125","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.hlc.2011.07.013","article-title":"Guidelines for genetic testing of inherited cardiac disorders","volume":"20","author":"Ingles","year":"2011","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.pcad.2026.09.002_bb0135","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.hrthm.2014.03.017","article-title":"Conveying a probabilistic genetic test result to families with an inherited heart disease","volume":"11","author":"Ingles","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0140","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American heart association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation [Internet]"},{"key":"10.1016\/j.pcad.2026.09.002_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-based assessment of genes in dilated cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0150","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2026.09.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.11.009","article-title":"An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinic","volume":"25","author":"Mohananey","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0160","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","article-title":"The cardiomyopathy registry of the EURObservational research programme of the European society of cardiology: baseline data and contemporary management of adult patients with cardiomyopathies","volume":"39","author":"Charron","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1272433","article-title":"Real-world utilization of guideline-directed genetic testing in inherited cardiovascular diseases","volume":"10","author":"Longoni","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0170","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cardfail.2025.11.496","article-title":"Real-world genetic testing practices in cardiomyopathy: national insights from 1.7 million patients","volume":"32","author":"Bui","year":"2026","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101910","article-title":"Cardiologists\u2019 perceptions of cardiogenetic testing and management","volume":"4","author":"Tang","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.pcad.2026.09.002_bb0180","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/eurheartj\/ehag159","article-title":"Genetic counselling implementation in dilated cardiomyopathy","volume":"47","author":"Verdonschot","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0185","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jacc.2022.06.040","article-title":"Clinical risk score to predict pathogenic genotypes in patients with dilated cardiomyopathy","volume":"80","author":"Escobar-Lopez","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0190","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/eurheartj\/ehag159","article-title":"Genetic counselling implementation in dilated cardiomyopathy","volume":"47","author":"Verdonschot","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0195","first-page":"1498","article-title":"Genetic testing for inherited cardiomyopathies: a clinical practice resource of the American college of medical genetics and genomics (ACMG)","volume":"23","author":"Ingles","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0200","author":"States U"},{"key":"10.1016\/j.pcad.2026.09.002_bb0205","author":"States U"},{"key":"10.1016\/j.pcad.2026.09.002_bb0210","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/AOG.0000000000002020","article-title":"Committee opinion no. 693: counseling about genetic testing and communication of genetic test results","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0215","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/eurheartj\/ehae747","article-title":"Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC council on cardiovascular genomics","volume":"46","author":"Elliott","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13073-024-01390-9","article-title":"Cardiomyopathies in 100,000 genomes project: interval evaluation improves diagnostic yield and informs strategies for ongoing gene discovery","volume":"16","author":"Josephs","year":"2024","journal-title":"Genome Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0225","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3390\/jcm9072111","article-title":"The multifaced perspectives of genetic testing in pediatric cardiomyopathies and channelopathies","volume":"9","author":"Popa-Fotea","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.pcad.2026.09.002_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000086","article-title":"Genetic testing for heritable cardiovascular diseases in pediatric patients: a scientific statement from the American heart association","volume":"14","author":"Landstrom","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0235","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/mus.25445","article-title":"Cardiac involvement in female carriers of Duchenne or Becker muscular dystrophy","volume":"55","author":"Mccaffrey","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pcad.2026.09.002_bb0240","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0245","first-page":"547","article-title":"Cardiomyopathies and genetic testing in heart failure: role in defining phenotype-targeted approaches and management","volume":"37","author":"Yogasundaram","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0250","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pcad.2026.09.002_bb0255","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/gim.2017.258","article-title":"CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation","volume":"20","author":"Whiffin","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0260","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pcad.2026.09.002_bb0265","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","article-title":"PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0270","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/gim.2016.40","article-title":"A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation","volume":"18","author":"Hunter","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/cen.14818","article-title":"Approach to the patient with a variant of uncertain significance on genetic testing","volume":"97","author":"Newey","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pcad.2026.09.002_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2026.102583","article-title":"Points to consider for the reporting of variants of uncertain significance in germline genetic and genomic testing: a statement of the American college of medical genetics and genomics (ACMG)","volume":"28","author":"Mighton","year":"2026","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0285","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2021.08.039","article-title":"Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy","volume":"78","author":"Escobar-Lopez","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0290","series-title":"GeneReviews\u00ae","article-title":"Titin-associated dilated cardiomyopathy [internet]","author":"Herman","year":"2014"},{"key":"10.1016\/j.pcad.2026.09.002_bb0295","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/hh2301.100981","article-title":"The complete gene sequence of titin, expression of an unusual \u2248700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system","volume":"89","author":"Bang","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2026.09.002_bb0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrcardio.2017.190","article-title":"Role of titin in cardiomyopathy: from DNA variants to patient stratification","volume":"15","author":"Ware","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0305","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/CIRCGEN.123.004062","article-title":"Genetic contribution to end-stage cardiomyopathy requiring heart transplantation","volume":"16","author":"Kim","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0310","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCGENETICS.110.937805","article-title":"Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy","volume":"3","author":"Elliott","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0315","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/europace\/euab183","article-title":"Clinical characteristics and risk stratification of desmoplakin cardiomyopathy","volume":"24","author":"Wang","year":"2022","journal-title":"EP Europace"},{"key":"10.1016\/j.pcad.2026.09.002_bb0320","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jcmg.2020.07.028","article-title":"Inflammatory episodes of desmoplakin cardiomyopathy masquerading as myocarditis","volume":"14","author":"Alley","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2026.09.002_bb0325","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/eurheartj\/ehae571","article-title":"Clinical features and outcomes in carriers of pathogenic desmoplakin variants","volume":"46","author":"Gasperetti","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032490","article-title":"DSP-related cardiomyopathy as a distinct clinical entity? Emerging evidence from an Italian cohort","volume":"24","author":"Di Lorenzo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pcad.2026.09.002_bb0335","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.hrthm.2024.12.035","article-title":"Endurance exercise promotes episodes of myocardial injury in individuals with a pathogenic desmoplakin (DSP) variant","volume":"22","author":"Jacobsen","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0340","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10741-015-9487-6","article-title":"BAG3: a new player in the heart failure paradigm","volume":"20","author":"Knezevic","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pcad.2026.09.002_bb0345","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","article-title":"Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations","volume":"72","author":"Dom\u00ednguez","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0350","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jacc.2018.05.065","article-title":"Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"72","author":"Gandjbakhch","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0355","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.devcel.2019.04.020","article-title":"Mechanosensing by the lamina protects against nuclear rupture, DNA damage, and cell-cycle arrest","volume":"49","author":"Cho","year":"2019","journal-title":"Dev Cell"},{"key":"10.1016\/j.pcad.2026.09.002_bb0360","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1083\/jcb.200904124","article-title":"Role of A-type lamins in signaling, transcription, and chromatin organization","volume":"187","author":"Andr\u00e9s","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0365","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","article-title":"Lamin A\/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy","volume":"156","author":"Parks","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0370","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of Lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001622","article-title":"Timing of pacemaker and ICD implantation in LMNA mutation carriers","volume":"8","author":"Ollila","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.pcad.2026.09.002_bb0380","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004357","article-title":"Multicenter experience with catheter ablation for ventricular tachycardia in Lamin A\/C cardiomyopathy","volume":"9","author":"Kumar","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0385","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0390","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cardfail.2013.03.001","article-title":"Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy","volume":"19","author":"Brodt","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0395","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2021.09.029","article-title":"Filamin-C variant-associated cardiomyopathy: a pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death","volume":"19","author":"Celeghin","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0400","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","article-title":"Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell\u2013cell adhesion structures","volume":"4","author":"Begay","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0405","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamacardio.2021.1106","article-title":"Association of left ventricular systolic dysfunction among carriers of truncating variants in Filamin C with frequent ventricular arrhythmia and end-stage heart failure","volume":"6","author":"Akhtar","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0410","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cge.13594","article-title":"FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations","volume":"96","author":"Ader","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0415","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.121.053521","article-title":"Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by Filamin C truncating variants","volume":"144","author":"Gigli","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0420","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jacc.2006.06.045","article-title":"Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"48","author":"Dalal","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0425","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2022.03.1225","article-title":"European heart rhythm association (EHRA)\/heart rhythm society (HRS)\/Asia Pacific heart rhythm society (APHRS)\/Latin American heart rhythm society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases","volume":"19","author":"Wilde","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0430","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/europace\/eut224","article-title":"Screening of genes encoding junctional candidates in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"15","author":"Gandjbakhch","year":"2013","journal-title":"EP Europace"},{"key":"10.1016\/j.pcad.2026.09.002_bb0435","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"Van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0440","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"Van Der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0445","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers\u2013reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0450","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","article-title":"RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling","volume":"138","author":"Van Den Hoogenhof","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0455","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005700","article-title":"Pathogenic RBM20 -variants are associated with a severe disease expression in male patients with dilated cardiomyopathy","volume":"12","author":"Hey","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0460","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","article-title":"Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy","volume":"12","author":"Parikh","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0465","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamacardio.2026.0401","article-title":"RBM20 truncating variants and human cardiomyopathy","volume":"11","author":"Floyd","year":"2026","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0470","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.3390\/jcm14165611","article-title":"The natural history and clinical outcomes of transmembrane protein 43 cardiomyopathy: a systematic review","volume":"14","author":"Cecere","year":"2025","journal-title":"JCM"},{"key":"10.1016\/j.pcad.2026.09.002_bb0475","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003589","article-title":"Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L mutation in TMEM43 following implantable cardioverter defibrillator therapy","volume":"9","author":"Hodgkinson","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0480","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hrthm.2022.11.024","article-title":"Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies\u2014external validation of the LMNA-risk ventricular tachyarrhythmia calculator","volume":"20","author":"Rootwelt-Norberg","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0485","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/eurheartj\/ehac180","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"43","author":"Cadrin-Tourigny","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0490","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008509","article-title":"Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration","volume":"14","author":"Cadrin-Tourigny","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100832","article-title":"Long-term arrhythmic follow-up and risk stratification of patients with desmoplakin-associated arrhythmogenic right ventricular cardiomyopathy","volume":"3","author":"Gasperetti","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.pcad.2026.09.002_bb0500","first-page":"2968","article-title":"A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers","volume":"45","author":"Carrick","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0505","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039125","article-title":"Exercise prescription in arrhythmogenic cardiomyopathy: finding the right balance between risks and benefits","volume":"14","author":"Dei","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2026.09.002_bb0510","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tcm.2015.01.004","article-title":"Molecular mechanisms of peripartum cardiomyopathy: a vascular\/hormonal hypothesis","volume":"25","author":"Bello","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0515","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCULATIONAHA.120.052395","article-title":"Genetic and phenotypic landscape of peripartum cardiomyopathy","volume":"143","author":"Goli","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0520","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy","volume":"35","author":"Van Spaendonck-Zwarts","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0525","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy\u2013induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0530","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2022.03.010","article-title":"Genetics of cancer therapy-associated cardiotoxicity","volume":"167","author":"Kim","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0535","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/eurheartj\/ehae362","article-title":"Alcoholic cardiomyopathy: an update","volume":"45","author":"Dom\u00ednguez","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0540","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003240","article-title":"Clinical impact of secondary risk factors in TTN -mediated dilated cardiomyopathy","volume":"14","author":"Giudicessi","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0545","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic etiology for alcohol-induced cardiac toxicity","volume":"71","author":"Ware","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0550","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.058457","article-title":"Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy","volume":"146","author":"Lota","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0555","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003250","article-title":"Pathogenic variants associated with dilated cardiomyopathy predict outcome in pediatric myocarditis","volume":"14","author":"Seidel","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0560","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","article-title":"2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis","volume":"85","author":"Drazner","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0565","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jchf.2024.08.011","article-title":"Genetic landscape of patients with dilated cardiomyopathy and a systemic immune-mediated disease","volume":"13","author":"Stroeks","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0570","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0575","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/cvr\/cvab328","article-title":"Titin (TTN): from molecule to modifications, mechanics, and medical significance","volume":"118","author":"Loescher","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcad.2026.09.002_bb0580","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.119.045118","article-title":"Distinct cardiac transcriptomic clustering in titin and Lamin A\/C-associated dilated cardiomyopathy patients","volume":"142","author":"Verdonschot","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0585","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2020.12.072","article-title":"Contemporary and future approaches to precision medicine in inherited cardiomyopathies","volume":"77","author":"Fatkin","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0590","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jmg-2024-110208","article-title":"Reassessment and reclassification of variants of unknown significance in patients with cardiomyopathy in a specialist department","volume":"62","author":"Horgan","year":"2025","journal-title":"J Med Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0595","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41436-018-0391-z","article-title":"Patient re-contact after revision of genomic test results: points to consider\u2014a statement of the American college of medical genetics and genomics (ACMG)","volume":"21","author":"David","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0600","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41569-024-01073-3","article-title":"Reproductive options and genetic testing for patients with an inherited cardiac disease","volume":"22","author":"Verdonschot","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0605","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012937","article-title":"Exercise is associated with impaired left ventricular systolic function in patients with Lamin A\/C genotype","volume":"9","author":"Skj\u00f8lsvik","year":"2020","journal-title":"JAHA"},{"key":"10.1016\/j.pcad.2026.09.002_bb0610","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.09.002_bb0615","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jcmg.2018.05.017","article-title":"Prediction of life-threatening ventricular arrhythmia in patients with arrhythmogenic cardiomyopathy","volume":"11","author":"Lie","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2026.09.002_bb0620","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.181","article-title":"Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members","volume":"16","author":"Saberniak","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0625","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.117.027828","article-title":"Safety of sports for athletes with implantable cardioverter-defibrillators: long-term results of a prospective multinational registry","volume":"135","author":"Lampert","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.09.002_bb0630","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy\u2013associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0635","article-title":"Clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities: a scientific statement from the American heart association and American college of cardiology","volume":"151","author":"Kim","year":"2025","journal-title":"Circulation [Internet]"},{"key":"10.1016\/j.pcad.2026.09.002_bb0640","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrthm.2015.08.035","article-title":"Safety of American heart association-recommended minimum exercise for desmosomal mutation carriers","volume":"13","author":"Sawant","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0645","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.hrthm.2020.02.028","article-title":"Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy","volume":"17","author":"Paulin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2026.103043","article-title":"Genetic testing after heart transplantation uncovers heritable disease and drives family screening","volume":"5","author":"Moliner-Ab\u00f3s","year":"2026","journal-title":"JACC Adv"},{"key":"10.1016\/j.pcad.2026.09.002_bb0655","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.jacc.2025.09.1511","article-title":"Danicamtiv, a selective agonist of cardiac myosin, for dilated cardiomyopathy","volume":"86","author":"Lakdawala","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.pcad.2026.09.002_bb0660","series-title":"A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-DCM) [Internet]","author":"Cytokinetics, Inc","year":"2026"},{"key":"10.1016\/j.pcad.2026.09.002_bb0665","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jchf.2023.09.015","article-title":"Applications of gene therapy in cardiomyopathies","volume":"12","author":"Argiro","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pcad.2026.09.002_bb0670","series-title":"Genetic Causes of Cardiac Disease","first-page":"45","article-title":"The genetic landscape of cardiomyopathies [internet]","author":"Gerull","year":"2019"},{"key":"10.1016\/j.pcad.2026.09.002_bb0675","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/s41467-021-25439-0","article-title":"Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy","volume":"12","author":"Grote Beverborg","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.pcad.2026.09.002_bb0680","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade1633","article-title":"Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy","volume":"14","author":"Nishiyama","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0685","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.omtn.2017.12.012","article-title":"Gene therapy via trans-splicing for LMNA-related congenital muscular dystrophy","volume":"10","author":"Azibani","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.pcad.2026.09.002_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313147","article-title":"Unveiling the future of cardiac care: a review of gene therapy in cardiomyopathies","volume":"25","author":"Venturiello","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pcad.2026.09.002_bb0695","series-title":"Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a PKP2 Pathogenic Variant [Internet]","author":"Lexeo Therapeutics","year":"2024"},{"key":"10.1016\/j.pcad.2026.09.002_bb0700","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41536-025-00401-6","article-title":"Preclinical efficacy and safety of AAVrh10-based plakophilin-2 gene therapy (LX2020) as a treatment for arrhythmogenic cardiomyopathy","volume":"10","author":"Zhang","year":"2025","journal-title":"npj Regener Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0705","series-title":"A Phase 1 Dose Escalation Trial of RP-A601 in Subjects with PKP2 Variant-Mediated arrhythmogenic Cardiomyopathy (PKP2-ACM) [Internet]","author":"Rocket Pharmaceuticals, Inc.","year":"2024"},{"key":"10.1016\/j.pcad.2026.09.002_bb0710","series-title":"Open-Label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults with PKP2 Mutation-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (RIDGE-1) [Internet]","author":"Tenaya Therapeutics","year":"2024"},{"key":"10.1016\/j.pcad.2026.09.002_bb0715","series-title":"Early Treatment with Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial) (EARLY-GENE) [Internet]","author":"Sol\u00e1","year":"2024"},{"key":"10.1016\/j.pcad.2026.09.002_bb0720","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tcm.2022.01.011","article-title":"Clinical applicability of artificial intelligence for patients with an inherited heart disease: a scoping review","volume":"33","author":"Bleijendaal","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0725","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/apc.apc_90_23","article-title":"Katz-Wachtel phenomenon in an adult with dilated cardiomyopathy","volume":"16","author":"Bhasin","year":"2023","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0730","article-title":"Dilated cardiomyopathy caused by mutation of the PNPLA2 gene: a case report and literature review","volume":"15","author":"Wang","year":"2024","journal-title":"Front Genet"},{"key":"10.1016\/j.pcad.2026.09.002_bb0735","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1573403X10666140514102928","article-title":"The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia","volume":"10","author":"Zhang","year":"2014","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"10.1016\/j.pcad.2026.09.002_bb0740","first-page":"e3979","article-title":"\u201cAcing\u201d the hidden spade: review of diagnosis, follow-up, prognosis, and various associations of apical variant hypertrophic cardiomyopathy","volume":"11","author":"Patel","year":"2019","journal-title":"Cureus [Internet]"},{"key":"10.1016\/j.pcad.2026.09.002_bb0745","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0972-6292(16)30608-8","article-title":"Idiopathic ventricular tachycardia arising from the right ventricular apex","volume":"13","author":"Letsas","year":"2013","journal-title":"Indian Pacing Electrophysiol J"},{"issue":"11","key":"10.1016\/j.pcad.2026.09.002_bb0750","first-page":"e19568","article-title":"Transient left bundle branch block in the setting of cardiogenic pulmonary edema","volume":"13","author":"Elgassim","year":"2021","journal-title":"Cureus [Internet]"},{"key":"10.1016\/j.pcad.2026.09.002_bb0755","doi-asserted-by":"crossref","first-page":"280","DOI":"10.31083\/j.rcm2308280","article-title":"Echocardiography in the diagnosis of cardiomyopathies: current status and future directions","volume":"23","author":"Trasca","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0760","series-title":"GeneReviews\\textsuperscript\u00ae","article-title":"Arrhythmogenic right ventricular cardiomyopathy overview [internet]","author":"McNally","year":"1993"},{"key":"10.1016\/j.pcad.2026.09.002_bb0765","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5144\/0256-4947.2014.415","article-title":"Arrhythmogenic right ventricular cardiomyopathy\/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up","volume":"34","author":"Al-Ghamdi","year":"2014","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0770","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/joa3.12012","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"34","author":"Cho","year":"2018","journal-title":"J Arrhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0775","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.3390\/jcm11226607","article-title":"Association of whole-heart myocardial mechanics by transthoracic echocardiography with presence of late gadolinium enhancement by CMR in non-ischemic dilated cardiomyopathy","volume":"11","author":"M\u0117linyt\u0117-Ankudavi\u010d\u0117","year":"2022","journal-title":"JCM"},{"key":"10.1016\/j.pcad.2026.09.002_bb0780","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/medicina59030439","article-title":"Cardiovascular magnetic resonance imaging in familial dilated cardiomyopathy","volume":"59","author":"Lau","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.pcad.2026.09.002_bb0785","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12968-014-0050-8","article-title":"Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update","volume":"16","author":"te Riele","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2026.09.002_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2025.101867","article-title":"Imaging features of desmoplakin arrhythmogenic cardiomyopathy: a comparative cardiovascular magnetic resonance study","volume":"27","author":"Laredo","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2026.09.002_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd12070275","article-title":"Left ventricular ring-like pattern: the arrhythmic tale of a scarred heart","volume":"12","author":"Parisi","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.pcad.2026.09.002_bb0800","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2310335","article-title":"New diagnostic approach to arrhythmogenic cardiomyopathy: the Padua criteria","volume":"23","author":"Graziano","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131447","article-title":"Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European task force consensus report","volume":"395","author":"Corrado","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0810","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American college of medical genetics and genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.pcad.2026.09.002_bb0815","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0820","series-title":"GeneReviews\u00ae","article-title":"Dilated cardiomyopathy overview [internet]","author":"Hershberger","year":"2009"},{"key":"10.1016\/j.pcad.2026.09.002_bb0825","series-title":"GeneReviews\u00ae","article-title":"Hypertrophic cardiomyopathy overview [internet]","author":"Ingles","year":"2001"},{"key":"10.1016\/j.pcad.2026.09.002_bb0830","series-title":"GeneReviews\u00ae","article-title":"Danon disease [internet]","author":"D\u2019Souza","year":"2014"},{"key":"10.1016\/j.pcad.2026.09.002_bb0835","series-title":"GeneReviews\u00ae","article-title":"Desminopathy [internet]","author":"Brodehl","year":"2020"},{"key":"10.1016\/j.pcad.2026.09.002_bb0840","series-title":"GeneReviews\u00ae","article-title":"Arrhythmogenic right ventricular cardiomyopathy [internet]","author":"James","year":"2000"},{"key":"10.1016\/j.pcad.2026.09.002_bb0845","series-title":"GeneReviews\u00ae","article-title":"Emery-Dreifuss muscular dystrophy [internet]","author":"Waldm\u00fcller","year":"2007"},{"key":"10.1016\/j.pcad.2026.09.002_bb0850","series-title":"GeneReviews\u00ae","article-title":"LMNA-related dilated cardiomyopathy [internet]","author":"Hershberger","year":"2010"},{"key":"10.1016\/j.pcad.2026.09.002_bb0855","series-title":"GeneReviews\u00ae","article-title":"Mitochondrial DNA-associated cardiomyopathy and myopathy [internet]","author":"Scaglia","year":"2012"},{"key":"10.1016\/j.pcad.2026.09.002_bb0860","series-title":"GeneReviews\u00ae","article-title":"Myofibrillar myopathy [internet]","author":"Selcen","year":"2009"},{"issue":"5","key":"10.1016\/j.pcad.2026.09.002_bb0865","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.09.002_bb0870","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.hrthm.2025.10.043","article-title":"Disease penetrance and phenotypic spectrum of desmoplakin variant carriers in the population","volume":"23","author":"Gurumoorthi","year":"2026","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2026.09.002_bb0875","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jacc.2019.12.058","article-title":"Emerging techniques for risk stratification in nonischemic dilated cardiomyopathy","volume":"75","author":"Marrow","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:46:21Z","timestamp":1789764381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062026001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":175,"alternative-id":["S0033062026001015"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2026.09.002","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing for dilated and arrhythmogenic cardiomyopathies \u2013 A primer for cardiologists","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}